Guerbet Investor Relations Material
Latest events
H2 2023
Guerbet
Q1 2025 TU
24 Apr, 2025
H2 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Guerbet SA
Access all reports
Guerbet SA is a France-based healthcare company specializing in the development, manufacture, and distribution of diagnostic imaging products, particularly contrast agents used in medical imaging. Guerbet offers a comprehensive range of imaging solutions for Computed Tomography (CT)/Cath Lab examinations, Magnetic Resonance Imaging (MRI), and interventional imaging. Their product lineup includes iodinated active ingredients for CT/Cath Lab contrast agents and gadolinium complexes for MRI. The company is headquartered in Villepinte, France, and its shares are listed on the Euronext Paris.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
GBT
Country
🇫🇷 France